Sequence, structure, function, immunity: Structural genomics of costimulation

Immunological Reviews

Volumn 229, Issue 1, 2009, Pages 356-386

  Chattopadhyay, Kausik ^a   Lazar Molnar, Eszter ^a   Yan, Qingrong ^a   Rubinstein, Rotem ^a   Zhan, Chenyang ^a   Vigdorovich, Vladimir ^a   Ramagopal, Udupi A ^a   Bonanno, Jeffrey ^a   Nathenson, Stanley G ^a   Almo, Steven C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Immunoglobulin superfamily; Structure; T cell costimulation; TNF TNFR superfamily

Indexed keywords

CD28 ANTIGEN; CELL ADHESION MOLECULE; CELL SURFACE RECEPTOR; CHEMOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; IMMUNOGLOBULIN; INDUCIBLE COSTIMULATOR RECEPTOR; KIDNEY INJURY MOLECULE 1; LECTIN; PROTEIN PROGRAMMED DEATH 1; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DIMERIZATION; GENE MUTATION; GENOME ANALYSIS; GENOMICS; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 65349102966     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2009.00778.x     Document Type: Review

References (132)

1. Perutz MF. Recent developments in the X-ray study of Haemoglobin. In Haemoglobin; A symposium based on a conference held at Cambridge in June 1948 in memory of Sir Joseph Barcroft, New York : Interscience Publishers Inc. 1949 : pp. 135 148.
2. Perutz MF, Muirhead H, Cox JM, Goaman LC. Three-dimensional Fourier synthesis of horse oxyhaemoglobin at 2.8 Å resolution: the atomic model. Nature 1968 219 : 131 139.
3. Almo SC, et al. Structural genomics of protein phosphatases. J Struct Funct Genomics 2007 8 : 121 140.
4. Page R, Deacon AM, Lesley SA, Stevens RC. Shotgun crystallization strategy for structural genomics II: crystallization conditions that produce high resolution structures for T. maritima proteins. J Struct Funct Genomics 2005 6 : 209 217.
5. Schwartz JC, Zhang X, Nathenson SG, Almo SC. Structural mechanisms of costimulation. Nat Immunol 2002 3 : 427 434.
6. Meyaard L, et al. LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 1997 7 : 283 290.
7. Meyaard L. The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 2008 83 : 799 803.
8. Lebbink RJ, et al. Collagens are functional, high affinity ligands for the inhibitory immune receptor LAIR-1. J Exp Med 2006 203 : 1419 1425.
9. Lebbink RJ, et al. Mouse leukocyte-associated Ig-like receptor-1 (mLAIR-1) functions as an inhibitory collagen-binding receptor on immune cells. Int Immunol 2007 19 : 1011 1019.
10. Jansen CA, et al. Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 2007 37 : 914 924.
11. Martin AM, Kulski JK, Witt C, Pontarotti P, Christiansen FT. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol 2002 23 : 81 88.
12. Lebbink RJ, et al. The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction. J Immunol 2008 180 : 1662 1669.
13. Stelzl U, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005 122 : 957 968.
14. Rual JF, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005 437 : 1173 1178.
15. Venkatesan K, et al. An empirical framework for binary interactome mapping. Nat Methods 2008 6 : 83 90.
16. Jeong H, Tombor B, Albert R, Oltvai ZN, Barabasi AL. The large-scale organization of metabolic networks. Nature 2000 407 : 651 654.
17. Higurashi M, Ishida T, Kinoshita K. Identification of transient hub proteins and the possible structural basis for their multiple interactions. Protein Sci 2008 17 : 72 78.
18. Jeong H, Mason SP, Barabasi AL, Oltvai ZN. Lethality and centrality in protein networks. Nature 2001 411 : 41 42.
19. Pitti RM, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998 396 : 699 703.
20. Yu KY, Kwon B, Ni J, Zhai Y, Ebner R, Kwon BS. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999 274 : 13733 13736.
21. Migone TS, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002 16 : 479 492.
22. Takai Y, Miyoshi J, Ikeda W, Ogita H. Nectins and nectin-like molecules:roles in contact inhibition of cell movement and proliferation. Nat Rev Mol Cell Biol 2008 9 : 603 615.
23. Yu X, et al. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol 2009 10 : 48 57.
24. Dong X, et al. Crystal structure of the V domain of human Nectin-like molecule-1/Syncam3/Tsll1/Igsf4b, a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule. J Biol Chem 2006 281 : 10610 10617.
25. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002 2 : 116 126.
26. Chen L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 2004 4 : 336 347.
27. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005 23 : 515 548.
28. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006 24 : 65 97.
29. Acuto O, Michel F. CD28-mediated co-stimulation: a quantitative support for TCR signalling. Nat Rev Immunol 2003 3 : 939 951.
30. Waterhouse P, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995 270 : 985 988.
31. Okazaki T, Iwai Y, Honjo T. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr Opin Immunol 2002 14 : 779 782.
32. Young JR, Davison TF, Tregaskes CA, Rennie MC, Vainio O. Monomeric homologue of mammalian CD28 is expressed on chicken T cells. J Immunol 1994 152 : 3848 3851.
33. Schwartz JC, Zhang X, Fedorov AA, Nathenson SG, Almo SC. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001 410 : 604 608.
34. Stamper CC, et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001 410 : 608 611.
35. Ostrov DA, Shi W, Schwartz JC, Almo SC, Nathenson SG. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000 290 : 816 819.
36. Evans EJ, et al. Crystal structure of a soluble CD28-Fab complex. Nat Immunol 2005 6 : 271 279.
37. Kariv I, Truneh A, Sweet RW. Analysis of the site of interaction of CD28 with its counter-receptors CD80 and CD86 and correlation with function. J Immunol 1996 157 : 29 38.
38. Peach RJ, et al. Complementarity determining region 1 (CDR1)- and CDR3-analogous regions in CTLA-4 and CD28 determine the binding to B7-1. J Exp Med 1994 180 : 2049 2058.
39. Truneh A, et al. Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesis. Mol Immunol 1996 33 : 321 334.
40. Bhatia S, Edidin M, Almo SC, Nathenson SG. Different cell surface oligomeric states of B7-1 and B7-2: implications for signaling. Proc Natl Acad Sci USA 2005 102 : 15569 15574.
41. Chattopadhyay K, Bhatia S, Fiser A, Almo SC, Nathenson SG. Structural basis of inducible costimulator ligand costimulatory function: determination of the cell surface oligomeric state and functional mapping of the receptor binding site of the protein. J Immunol 2006 177 : 3920 3929.
42. Ikemizu S, et al. Structure and dimerization of a soluble form of B7-1. Immunity 2000 12 : 51 60.
43. Collins AV, et al. The interaction properties of costimulatory molecules revisited. Immunity 2002 17 : 201 210.
44. Grohmann U, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002 3 : 1097 1101.
45. Stone JD, Chervin AS, Kranz DM. T-cell receptor binding affinities and kinetics:impact on T-cell activity and specificity. Immunology 2009 126 : 165 176.
46. Bromley SK, et al. The immunological synapse. Annu Rev Immunol 2001 19 : 375 396.
47. Choudhuri K, Wiseman D, Brown MH, Gould K, Van der Merwe PA. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand. Nature 2005 436 : 578 582.
48. Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006 27 : 195 201.
49. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999 11 : 141 151.
50. Nishimura H, et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001 291 : 319 322.
51. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 2007 8 : 239 245.
52. Barber DL, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006 439 : 682 687.
53. Day CL, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006 443 : 350 354.
54. Lazar-Molnar E, Gacser A, Freeman GJ, Almo SC, Nathenson SG, Nosanchuk JD. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci USA 2008 105 : 2658 2663.
55. Finger LR, et al. The human PD-1 gene: complete cDNA, genomic organization, and developmentally regulated expression in B cell progenitors. Gene 1997 197 : 177 187.
56. Zhang X, et al. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004 20 : 337 347.
57. Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007 27 : 111 122.
58. Lin DY, et al. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci USA 2008 105 : 3011 3016.
59. Lazar-Molnar E, Yan Q, Cao E, Ramagopal U, Nathenson SG, Almo SC. Crystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2. Proc Natl Acad Sci USA 2008 105 : 10483 10488.
60. Larsen CP, et al. Rational development of LEA29Y (belatacept), a high-affinity variant of CTLA4-Ig with potent immunosuppressive properties. Am J Transplant 2005 5 : 443 453.
61. Vincenti F, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005 353 : 770 781.
62. Kuchroo VK, Dardalhon V, Xiao S, Anderson AC. New roles for TIM family members in immune regulation. Nat Rev Immunol 2008 8 : 577 580.
63. Meyers JH, Sabatos CA, Chakravarti S, Kuchroo VK. The TIM gene family regulates autoimmune and allergic diseases. Trends Mol Med 2005 11 : 362 369.
64. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 2003 3 : 454 462.
65. Santiago C, Ballesteros A, Tami C, Martinez-Munoz L, Kaplan GG, Casasnovas JM. Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity 2007 26 : 299 310.
66. Chakravarti S, et al. Tim-2 regulates T helper type 2 responses and autoimmunity. J Exp Med 2005 202 : 437 444.
67. Monney L, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 2002 415 : 536 541.
68. Umetsu SE, et al. TIM-1 induces T cell activation and inhibits the development of peripheral tolerance. Nat Immunol 2005 6 : 447 454.
69. Degauque N, et al. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J Clin Invest 2008 118 : 735 741.
70. Ueno T, et al. The emerging role of T cell Ig mucin 1 in alloimmune responses in an experimental mouse transplant model. J Clin Invest 2008 118 : 742 751.
71. Meyers JH, et al. TIM-4 is the ligand for TIM-1, and the TIM-1-TIM-4 interaction regulates T cell proliferation. Nat Immunol 2005 6 : 455 464.
72. Wilker PR, Sedy JR, Grigura V, Murphy TL, Murphy KM. Evidence for carbohydrate recognition and homotypic and heterotypic binding by the TIM family. Int Immunol 2007 19 : 763 773.
73. Sizing ID, et al. Epitope-dependent effect of anti-murine TIM-1 monoclonal antibodies on T cell activity and lung immune responses. J Immunol 2007 178 : 2249 2261.
74. Chen TT, et al. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 2005 202 : 955 965.
75. Kumanogoh A, et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature 2002 419 : 629 633.
76. Fargion S, Fracanzani AL, Brando B, Arosio P, Levi S, Fiorelli G. Specific binding sites for H-ferritin on human lymphocytes: modulation during cellular proliferation and potential implication in cell growth control. Blood 1991 78 : 1056 1061.
77. Zhu C, et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 2005 6 : 1245 1252.
78. Jones RB, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 2008 205 : 2763 2779.
79. Cao E, et al. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity 2007 26 : 311 321.
80. Santiago C, et al. Structures of T cell immunoglobulin mucin protein 4 show a metal-Ion-dependent ligand binding site where phosphatidylserine binds. Immunity 2007 27 : 941 951.
81. Ichimura T, Asseldonk EJ, Humphreys BD, Gunaratnam L, Duffield JS, Bonventre JV. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest 2008 118 : 1657 1668.
82. Kobayashi N, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 2007 27 : 927 940.
83. Miyanishi M, Tada K, Koike M, Uchiyama Y, Kitamura T, Nagata S. Identification of Tim4 as a phosphatidylserine receptor. Nature 2007 450 : 435 439.
84. Veillette A. Immune regulation by SLAM family receptors and SAP-related adaptors. Nat Rev Immunol 2006 6 : 56 66.
85. Calpe S, et al. The SLAM and SAP gene families control innate and adaptive immune responses. Adv Immunol 2008 97 : 177 250.
86. Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol 2003 4 : 19 24.
87. Yan Q, et al. Structure of CD84 provides insight into SLAM family function. Proc Natl Acad Sci USA 2007 104 : 10583 10588.
88. Latour S, Veillette A. The SAP family of adaptors in immune regulation. Semin Immunol 2004 16 : 409 419.
89. Latour S, Gish G, Helgason CD, Humphries RK, Pawson T, Veillette A. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol 2001 2 : 681 690.
90. Bloch-Queyrat C, et al. Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn. J Exp Med 2005 202 : 181 192.
91. Mavaddat N, et al. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J Biol Chem 2000 275 : 28100 28109.
92. Brown MH, Boles K, Anton van der Merwe P, Kumar V, Mathew PA, Neil Barclay A. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J Exp Med. 1998 188 : 2083 2090.
93. Flaig RM, Stark S, Watzl C. Cutting edge: NTB-A activates NK cells via homophilic interaction. J Immunol 2004 172 : 6524 6527.
94. Martin M, et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-[gamma] secretion: adhesion is mediated by Ig-like domain 1. J Immunol 2001 167 : 3668 3676.
95. Romero X, et al. CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse. J Immunol 2005 174 : 7033 7042.
96. Kumaresan PR, Lai WC, Chuang SS, Bennett M, Mathew PA. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol Immunol 2002 39 : 1 8.
97. Wang J-h, et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell 1999 97 : 791 803.
98. Van der Merwe PA, et al. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59. Biochemistry 1994 33 : 10149 10160.
99. Velikovsky CA, Deng L, Chlewicki LK, Fernandez MM, Kumar V, Mariuzza RA. Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family. Immunity 2007 27 : 572 584.
100. Cao E, et al. NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity 2006 25 : 559 570.
101. Wandstrat AE, et al. Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus. Immunity 2004 21 : 769 780.
102. Kumar KR, et al. Regulation of B cell tolerance by the lupus susceptibility gene Ly108. Science 2006 312 : 1665 1669.
103. Bodmer JL, Schneider P, Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem Sci 2002 27 : 19 26.
104. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001 104 : 487 501.
105. Watts TH. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 2005 23 : 23 68.
106. Compaan DM, Hymowitz SG. The crystal structure of the costimulatory OX40-OX40L complex. Structure 2006 14 : 1321 1330.
107. Chattopadhyay K, et al. Assembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for function. Proc Natl Acad Sci USA 2007 104 : 19452 19457.
108. Chattopadhyay K, Ramagopal UA, Brenowitz M, Nathenson SG, Almo SC. Evolution of GITRL immune function:murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily. Proc Natl Acad Sci USA 2008 105 : 635 640.
109. Zhou Z, et al. Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states. Proc Natl Acad Sci USA 2008 105 : 5465 5470.
110. Zhou Z, et al. Structural basis for ligand-mediated mouse GITR activation. Proc Natl Acad Sci USA 2008 105 : 641 645.
111. Nocentini G, Ronchetti S, Cuzzocrea S, Riccardi C. GITR/GITRL: more than an effector T cell co-stimulatory system. Eur J Immunol 2007 37 : 1165 1169.
112. Shevach EM, Stephens GL. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity? Nat Rev Immunol 2006 6 : 613 618.
113. Ji HB, et al. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004 172 : 5823 5827.
114. McHugh RS, et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002 16 : 311 323.
115. + T cells. J Immunol 2004 173 : 5008 5020.
116. Park YC, Burkitt V, Villa AR, Tong L, Wu H. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999 398 : 533 538.
117. Ye H, Park YC, Kreishman M, Kieff E, Wu H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999 4 : 321 330.
118. Eck MJ, Sprang SR. The structure of tumor necrosis factor-alpha at 2.6 Å resolution. Implications for receptor binding. J Biol Chem 1989 264 : 17595 17605.
119. Wingfield P, Pain RH, Craig S. Tumour necrosis factor is a compact trimer. FEBS Lett 1987 211 : 179 184.
120. Eissner G, Kolch W, Scheurich P. Ligands working as receptors: reverse signaling by members of the TNF superfamily enhance the plasticity of the immune system. Cytokine Growth Factor Rev 2004 15 : 353 366.
121. Baltz KM, et al. Cancer immunoediting by GITR (glucocorticoid-induced TNF-related protein) ligand in humans: NK cell/tumor cell interactions. FASEB J 2007 21 : 2442 2454.
122. Grohmann U, et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 2007 13 : 579 586.
123. Shin HH, Kim SJ, Lee HS, Choi HS. The soluble glucocorticoid-induced tumor necrosis factor receptor causes cell cycle arrest and apoptosis in murine macrophages. Biochem Biophys Res Commun 2004 316 : 24 32.
124. Shin HH, Lee MH, Kim SG, Lee YH, Kwon BS, Choi HS. Recombinant glucocorticoid induced tumor necrosis factor receptor (rGITR) induces NOS in murine macrophage. FEBS Lett 2002 514 : 275 280.
125. Gurney AL, et al. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr Biol 1999 9 : 215 218.
126. Tone M, et al. Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells. Proc Natl Acad Sci USA 2003 100 : 15059 15064.
127. Bossen C, et al. Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human. J Biol Chem 2006 281 : 13964 13971.
128. Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005 35 : 1016 1022.
129. + T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002 196 : 1335 1346.
130. Bennett MJ, Schlunegger MP, Eisenberg D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 1995 4 : 2455 2468.
131. Shannon P, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003 13 : 2498 2504.
132. Barton GJ. ALSCRIPT: a tool to format multiple sequence alignments. Protein Eng 1993 6 : 37 40.